Integral BioSystems to Participate in the 2010 PSWC/AAPS Expo in New Orleans Nov. 14-18

Sept. 10, 2010 - PRLog -- Integral BioSystems Announces its Participation in the 2010 International Pharmaceutical Federation's PSWC/AAPS Annual Meeting Exposition in New Orleans November 14 – 18

By Integral BioSystems, LLC
Dated: September 10, 2010

Boston area CRO Integral BioSystems, LLC announces its participation in the 2010 International Pharmaceutical Federation's PSWC/AAPS Annual Meeting Exposition in New Orleans November 14 - 18

“As we enter our third year as a Boston-area CRO, we are ready to bring the same level of expertise and commitment to solving the development needs of a more geographically diverse clientele as has been enjoyed by numerous Massachusetts pharmaceutical developers. With the increased size of our laboratory facilities and attendant equipment enhancements, we can serve the needs of a greater number of clients, and intend to do exactly that.”

-Dave Karasic, J.D.
V.P. Business Development/Legal/I.P.
Integral BioSystems, LLC
781-879-4677

About the Exposition
Per the event’s organizers: “For the first time, the AAPS Annual Meeting and Exposition will be held with the International Pharmaceutical Federation’s PSWC. The FIP Pharmaceutical Sciences World Congress 2010 in association with the AAPS Annual Meeting and Exposition, will bring together thousands of scientists from around the world with the goal of ‘Improving Global Health Through Advances in Pharmaceutical Sciences’, the scientific theme of this year’s event.”

About Integral BioSystems, LLC
Integral BioSystems, LLC, founded in 2008, has adopted a translational medicinal approach to drug development, customizing delivery systems to accomplish the biologically effective objectives of the therapy. Drug delivery systems are customized to achieve sustained release or targeted, tissue-focused delivery, or fast-release/instant delivery, depending upon the desired product attributes. The company has a network of manufacturers/analytical houses for pharmaceutics that can fast-track the manufacture and release of the sterile dosage form for first-in-man trials.

# # #

A Boston-area contract research organization, Integral BioSystems specializes in the development of ophthalmic, transdermal, intravenous, intranasal and oral dosage forms. Additionally, we offer services in intellectual property and contracts.